| Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non–small-cell lung cancer A Depierre, B Milleron, D Moro-Sibilot, S Chevret, E Quoix, B Lebeau, ... Journal of clinical oncology 20 (1), 247-253, 2002 | 953 | 2002 |
| Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort J Mazières, G Zalcman, L Crinò, P Biondani, F Barlesi, T Filleron, ... Journal of clinical oncology 33 (9), 992-999, 2015 | 427 | 2015 |
| In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy L Thiberville, S Moreno-Swirc, T Vercauteren, E Peltier, C Cavé, ... American journal of respiratory and critical care medicine 175 (1), 22-31, 2007 | 417 | 2007 |
| Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small … G Robinet, P Thomas, JL Breton, H Lena, S Gouva, G Dabouis, ... Annals of oncology 12 (1), 59-67, 2001 | 336 | 2001 |
| Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research … G Giaccone, C Debruyne, E Felip, PB Chapman, SC Grant, M Millward, ... Journal of clinical oncology 23 (28), 6854-6864, 2005 | 298 | 2005 |
| Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy L Thiberville, M Salaün, S Lachkar, S Dominique, S Moreno-Swirc, ... European Respiratory Journal 33 (5), 974-985, 2009 | 292 | 2009 |
| The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group E Thunnissen, KM Kerr, FJF Herth, S Lantuejoul, M Papotti, RC Rintoul, ... Lung cancer 76 (1), 1-18, 2012 | 268 | 2012 |
| Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy S Bota, JB Auliac, C Paris, J Métayer, R Sesboue, G Nouvet, L Thiberville American journal of respiratory and critical care medicine 164 (9), 1688-1693, 2001 | 264 | 2001 |
| Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial G Deslée, H Mal, H Dutau, A Bourdin, JM Vergnon, C Pison, R Kessler, ... Jama 315 (2), 175-184, 2016 | 263 | 2016 |
| Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus L Thiberville, P Payne, J Vielkinds, J LeRiche, D Horsman, G Nouvet, ... Cancer research 55 (22), 5133-5139, 1995 | 257 | 1995 |
| Development of a real-time flexible multiphoton microendoscope for label-free imaging in a live animal G Ducourthial, P Leclerc, T Mansuryan, M Fabert, J Brevier, R Habert, ... Scientific reports 5 (1), 18303, 2015 | 157 | 2015 |
| Confocal fluorescence endomicroscopy of the human airways L Thiberville, M Salaün, S Lachkar, S Dominique, S Moreno-Swirc, ... Proceedings of the American Thoracic Society 6 (5), 444-449, 2009 | 157 | 2009 |
| Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia … P Vera, P Bohn, A Edet-Sanson, A Salles, S Hapdey, I Gardin, JF Ménard, ... Radiotherapy and Oncology 98 (1), 109-116, 2011 | 147 | 2011 |
| Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled … A Dinh, J Ropers, C Duran, B Davido, L Deconinck, M Matt, O Senard, ... The Lancet 397 (10280), 1195-1203, 2021 | 137 | 2021 |
| Anti-PD1/PD-L1 immunotherapy for non-small cell lung cancer with actionable oncogenic driver mutations E Dantoing, N Piton, M Salaün, L Thiberville, F Guisier International journal of molecular sciences 22 (12), 6288, 2021 | 110 | 2021 |
| Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial JL Pujol, A Lavole, E Quoix, O Molinier, PJ Souquet, F Barlesi, H Le Caer, ... Annals of Oncology 26 (5), 908-914, 2015 | 105 | 2015 |
| Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections F Lamoureux, T Duflot, JB Woillard, D Metsu, T Pereira, P Compagnon, ... International journal of antimicrobial agents 47 (2), 124-131, 2016 | 100 | 2016 |
| Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: A prospective study in high‐risk patients without invasive … A Lamy, R Sesboüé, J Bourguignon, B Dautréaux, J Métayer, T Frébourg, ... International journal of cancer 100 (2), 189-193, 2002 | 82 | 2002 |
| Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers M Patout, M Salaün, V Brunel, S Bota, B Cauliez, L Thiberville Clinical biochemistry 47 (18), 263-267, 2014 | 78 | 2014 |
| Systemic therapy in advanced thymic epithelial tumors: insights from the RYTHMIC prospective cohort CM Du Vignaux, E Dansin, L Mhanna, L Greillier, E Pichon, M Kerjouan, ... Journal of Thoracic Oncology 13 (11), 1762-1770, 2018 | 75 | 2018 |
